CLC Bio, the commercial sequence analysis software specialist, has announced that the J. Craig Venter Institute (JCVI) has extended its site license agreement until 2017.
JCVI has been using CLC Bio’s enterprise platform since 2009 and currently uses it on more than 30 research grants, including its work as part of the Human Microbiome Project (HMP) – a National Institutes of Health-funded project to catalogue and characterise the microbes living in and on the human body. Recently, the HMP Consortium published a series of papers with results from this work in Nature and PLOSone. CLC Bio's software was used in the analysis of this work.
JCVI deploys CLC Bio’s platform in an integrated environment across multiple geographical locations and together with international collaborators.
'The complexity and diversity of our research projects necessitates unique tools to analyse these increasingly large data sets. In our pursuit of excellence we always test and employ the best available tools for our research projects. As such we’re happy to announce the extension of our site license with CLC Bio through 2017,' said Karen Nelson, president of JCVI.